Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • BioHak
    Member
    • Aug 2008
    • 13

    #1

    Hello from PharmLand -- Philadelphia

    Hi,
    I'm quite happy to have stumbled upon this resource, my group has had 3 FLX sequencers running for about 18months and they are now my responsibility. Hopefully I'll be able to give back to the group as I am sure after we purchase our 2 GA2's in the upcoming 6 months, I'll have some questions.

    Thanks,
    Genaro
  • bioinfosm
    Senior Member
    • Jan 2008
    • 483

    #2
    Hi there,
    What kind of applications with the FLX? And do you use the vendor software or some other tools as well?
    --
    bioinfosm

    Comment

    • BioHak
      Member
      • Aug 2008
      • 13

      #3
      We're using the FLX in drug discovery. A pool of compounds are covalently linked to a DNA tag which describes the "recipe" for making the compound. The pool of DNA is recovered after several stringent washes with a protein of interest.
      More info here: http://www.softconference.com/sbs/se...asp?SID=115614

      The basecalling is with the vanilla Roche product, but we do use a custom application for the deconvolution of the DNA "recipe."

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
        by SEQadmin2




        NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
        Yesterday, 06:46 AM
      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-28-2026, 09:57 AM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-28-2026, 09:51 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      71 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...